Serum levels of anti-SRP54 antibodies reflect disease activity of necrotizing myopathy in a child treated effectively with combinatorial methylprednisolone pulses and plasma exchanges followed by intravenous cyclophosphamide

Mei MomomuraDepartment of Pediatrics, Yokohama City University, Kanazawaku, Yokohama, Japan

Takako MiyamaeDepartment of Pediatrics, Yokohama City University, Kanazawaku, Yokohama, JapanCorrespondence[email protected]

Tomo NozawaDepartment of Pediatrics, Yokohama City University, Kanazawaku, Yokohama, Japan

Masako KikuchiDepartment of Pediatrics, Yokohama City University, Kanazawaku, Yokohama, Japan

Toshitaka KizawaDepartment of Pediatrics, Yokohama City University, Kanazawaku, Yokohama, Japan

Tomoyuki ImagawaDepartment of Pediatrics, Yokohama City University, Kanazawaku, Yokohama, Japan

Laurent DrouotLaboratory of Immunology, Inserm U905, University of Rouen and Rouen University Hospital, Rouen, France

Fabienne JouenLaboratory of Immunology, Inserm U905, University of Rouen and Rouen University Hospital, Rouen, France

Olivier BoyerLaboratory of Immunology, Inserm U905, University of Rouen and Rouen University Hospital, Rouen, France

Shumpei YokotaDepartment of Pediatrics, Yokohama City University, Kanazawaku, Yokohama, Japan

Articles from other publishers (9)